Defects in skeletal muscle subsarcolemmal mitochondria in a non-obese model of type 2 diabetes mellitus.
Level 5 - mechanism / opinion, no new human data
Animal model study without human data
PubMed 28850625 · doi:10.1371/journal.pone.0183978
What was done
Researchers evaluated the functional and biochemical properties of two skeletal muscle mitochondrial subpopulations—subsarcolemmal (SSM) and interfibrillar (IFM) mitochondria—in Goto-Kakizaki (GK) rats, a spontaneous non-obese animal model of type 2 diabetes mellitus. Polarographic and spectrophotometric assays were used to assess oxidative phosphorylation efficiency, respiratory chain components, inner mitochondrial membrane structure, and fatty acid transport and oxidation.
What was found
Interfibrillar mitochondrial respiratory function was preserved in diabetic rats, though interfibrillar palmitoyl-CoA increased by 25%. Subsarcolemmal mitochondria showed minor defects characterized by a mild decline in oxidative phosphorylation efficiency associated with ATP synthase and inner membrane structural alterations, but without upstream defects. Fatty acid transport and oxidation remained preserved across both mitochondrial subpopulations. No other numerical figures, error ranges, or p-values were reported in the abstract.
Why it matters
These findings challenge the concept that skeletal muscle mitochondrial dysfunction and impaired fatty acid oxidation are central drivers of insulin resistance in non-obese type 2 diabetes.
Limits
The study was conducted in a rodent model (Goto-Kakizaki rats), limiting direct translation to human pathology. The abstract does not report the sample size (n), precise quantitative values for most assays, or statistical variance.
Cited by
- supports Subsarcolemmal and interfibrillar mitochondria in skeletal muscle have different proteomic compositions, morphologies, rates of ATP synthesis, ROS production, and calcium handling capacities.